Last Updated :2024/12/13
Researcher Information
Research activity information
Paper
- Effect of the guideline education program on anticholinergic and benzodiazepine use in outpatients with schizophrenia and major depressive disorder: The effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE) project
Hirotaka Yamagata; Yuko Fujii; Shinichiro Ochi; Tomoe Seki; Naomi Hasegawa; Hisashi Yamada; Hikaru Hori; Kayo Ichihashi; Jun-ichi Iga; Kazuyoshi Ogasawara; Naoki Hashimoto; Hitoshi Iida; Kazutaka Ohi; Takashi Tsuboi; Shusuke Numata; Akitoyo Hishimoto; Masahide Usami; Eiichi Katsumoto; Hiroyuki Muraoka; Yoshikazu Takaesu; Tatsuya Nagasawa; Hiroshi Komatsu; Kenichiro Miura; Junya Matsumoto; Ken Inada; Shin Nakagawa; Ryota Hashimoto
Psychiatry Research Communications, Mar. 2024 - Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.
Naomi Hasegawa; Yuka Yasuda; Norio Yasui-Furukori; Hisashi Yamada; Hikaru Hori; Kayo Ichihashi; Yoshikazu Takaesu; Hitoshi Iida; Hiroyuki Muraoka; Fumitoshi Kodaka; Jun-Ichi Iga; Naoki Hashimoto; Kazuyoshi Ogasawara; Kazutaka Ohi; Kentaro Fukumoto; Shusuke Numata; Takashi Tsuboi; Masahide Usami; Akitoyo Hishimoto; Ryuji Furihata; Taishiro Kishimoto; Toshinori Nakamura; Eiichi Katsumoto; Shinichiro Ochi; Tatsuya Nagasawa; Kiyokazu Atake; Chika Kubota; Hiroshi Komatsu; Hirotaka Yamagata; Kenta Ide; Masahiro Takeshima; Mikio Kido; Saya Kikuchi; Tsuyoshi Okada; Junya Matsumoto; Kenichiro Miura; Taichi Shimazu; Ken Inada; Koichiro Watanabe; Ryota Hashimoto
Psychiatry and clinical neurosciences, Oct. 2023 - Japanese Society of Anxiety and Related Disorders/Japanese Society of Neuropsychopharmacology: Clinical practice guideline for social anxiety disorder (2021).
Satoshi Asakura; Naoki Yoshinaga; Hisashi Yamada; Yutaka Fujii; Nobuyuki Mitsui; Yoshihiro Kanai; Takeshi Inoue; Eiji Shimizu
Neuropsychopharmacology reports, Sep. 2023 - A prospective investigation of impacts of comorbid attention deficit hyperactivity disorder (ADHD) on clinical features and long-term treatment response in adult patients with obsessive-compulsive disorder (OCD).
Masahiro Miyauchi; Naomi Matsuura; Keiichiro Mukai; Takuya Hashimoto; Shun Ogino; Kyosuke Yamanishi; Hisashi Yamada; Kazuhisa Hayashida; Hisato Matsunaga
Comprehensive psychiatry, Aug. 2023 - Clinical practice for unspecified anxiety disorder in primary care
Hitoshi Sakurai; Masahiro Takeshima; Ken Inada; Yumi Aoki; Kenya Ie; Morito Kise; Eriko Yoshida; Takashi Tsuboi; Hisashi Yamada; Hikaru Hori; Yasushi Inada; Eiji Shimizu; Kazuo Mishima; Koichiro Watanabe; Yoshikazu Takaesu
Psychiatry and Clinical Neurosciences Reports, Jun. 2023 - Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project.
Naoki Hashimoto; Norio Yasui-Furukori; Naomi Hasegawa; Shuhei Ishikawa; Hikaru Hori; Hitoshi Iida; Kayo Ichihashi; Kenichiro Miura; Junya Matsumoto; Shusuke Numata; Fumitoshi Kodaka; Ryuji Furihata; Kazutaka Ohi; Kazuyoshi Ogasawara; Jun-Ichi Iga; Hiroyuki Muraoka; Hiroshi Komatsu; Masahiro Takeshima; Kiyokazu Atake; Mikio Kido; Toshinori Nakamura; Taishiro Kishimoto; Akitoyo Hishimoto; Toshiaki Onitsuka; Tsuyoshi Okada; Shinichiro Ochi; Tatsuya Nagasawa; Manabu Makinodan; Hiroki Yamada; Takashi Tsuboi; Hisashi Yamada; Ken Inada; Koichiro Watanabe; Ryota Hashimoto
BMC psychiatry, Jun. 2023 - Management of unspecified anxiety disorder: Expert consensus.
Hitoshi Sakurai; Ken Inada; Yumi Aoki; Masahiro Takeshima; Kenya Ie; Morito Kise; Eriko Yoshida; Takashi Tsuboi; Hisashi Yamada; Hikaru Hori; Yasushi Inada; Eiji Shimizu; Kazuo Mishima; Koichiro Watanabe; Yoshikazu Takaesu
Neuropsychopharmacology reports, Jun. 2023 - Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics
Toshiaki Onitsuka; Tsuyoshi Okada; Naomi Hasegawa; Takashi Tsuboi; Jun-ichi Iga; Norio Yasui-Furukori; Naoki Yamada; Hikaru Hori; Hiroyuki Muraoka; Kazutaka Ohi; Kazuyoshi Ogasawara; Shinichiro Ochi; Masahiro Takeshima; Kayo Ichihashi; Kentaro Fukumoto; Hitoshi Iida; Hisashi Yamada; Ryuji Furihata; Manabu Makinodan; Yoshikazu Takaesu; Shusuke Numata; Hiroshi Komatsu; Akitoyo Hishimoto; Mikio Kido; Kiyokazu Atake; Hirotaka Yamagata; Saya Kikuchi; Naoki Hashimoto; Masahide Usami; Eiichi Katsumoto; Takeshi Asami; Chika Kubota; Junya Matsumoto; Kenichiro Miura; Yoji Hirano; Koichiro Watanabe; Ken Inada; Ryota Hashimoto
Journal of Clinical Psychopharmacology, May 2023, [Reviewed] - [Antipsychotics].
Hisashi Yamada; Ryota Hashimoto
Brain and nerve = Shinkei kenkyu no shinpo, May 2023 - Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders.
Kentaro Fukumoto; Fumitoshi Kodaka; Naomi Hasegawa; Hiroyuki Muraoka; Hikaru Hori; Kayo Ichihashi; Yuka Yasuda; Hitoshi Iida; Kazutaka Ohi; Shinichiro Ochi; Kenta Ide; Naoki Hashimoto; Masahide Usami; Toshinori Nakamura; Hiroshi Komatsu; Tsuyoshi Okada; Tatsuya Nagasawa; Ryuji Furihata; Kiyokazu Atake; Mikio Kido; Saya Kikuchi; Hirotaka Yamagata; Taishiro Kishimoto; Manabu Makinodan; Tadasu Horai; Masahiro Takeshima; Chika Kubota; Takeshi Asami; Eiichi Katsumoto; Akitoyo Hishimoto; Toshiaki Onitsuka; Junya Matsumoto; Kenichiro Miura; Hisashi Yamada; Norio Yasui-Furukori; Koichiro Watanabe; Ken Inada; Kotaro Otsuka; Ryota Hashimoto
Neuropsychopharmacology reports, Mar. 2023 - Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project.
Hitoshi Iida; Tsuyoshi Okada; Kiyotaka Nemoto; Naomi Hasegawa; Shusuke Numata; Kazuyoshi Ogasawara; Kenichiro Miura; Junya Matsumoto; Hikaru Hori; Jun-Ichi Iga; Kayo Ichihashi; Naoki Hashimoto; Hisashi Yamada; Kazutaka Ohi; Norio Yasui-Furukori; Kentaro Fukumoto; Takashi Tsuboi; Masahide Usami; Ryuji Furihata; Yoshikazu Takaesu; Akitoyo Hishimoto; Hiroyuki Muraoka; Eiichi Katsumoto; Tatsuya Nagasawa; Shinichiro Ochi; Hiroshi Komatsu; Saya Kikuchi; Masahiro Takeshima; Toshiaki Onitsuka; Shinichiro Tamai; Chika Kubota; Ken Inada; Koichiro Watanabe; Hiroaki Kawasaki; Ryota Hashimoto
Neuropsychopharmacology reports, Mar. 2023 - Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score-matched analysis.
Takashi Tsuboi; Yoshikazu Takaesu; Naomi Hasegawa; Shinichiro Ochi; Kentaro Fukumoto; Kazutaka Ohi; Hiroyuki Muraoka; Tsuyoshi Okada; Funitoshi Kodaka; Shun Igarashi; Hitoshi Iida; Hiroko Kashiwagi; Hikaru Hori; Kayo Ichihashi; Kazuyoshi Ogasawara; Naoki Hashimoto; Jun-Ichi Iga; Toshinori Nakamura; Masahide Usami; Tatsuya Nagasawa; Mikio Kido; Hiroshi Komatsu; Hirotaka Yamagata; Kiyokazu Atake; Ryuji Furihata; Saya Kikuchi; Tadasu Horai; Masahiro Takeshima; Yoji Hirano; Manabu Makinodan; Junya Matsumoto; Kenichiro Miura; Akitoyo Hishimoto; Shusuke Numata; Hisashi Yamada; Norio Yasui-Furukori; Ken Inada; Koichiro Watanabe; Ryota Hashimoto
Psychiatry and clinical neurosciences, Jan. 2023 - The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project.
Yoshitaka Kyou; Norio Yasui-Furukori; Naomi Hasegawa; Kenta Ide; Kayo Ichihashi; Naoki Hashimoto; Hikaru Hori; Yoshihito Shimizu; Yayoi Imamura; Hiroyuki Muraoka; Hitoshi Iida; Kazutaka Ohi; Yuka Yasuda; Kazuyoshi Ogasawara; Shusuke Numata; Jun-Ichi Iga; Takashi Tsuboi; Shinichiro Ochi; Fumitoshi Kodaka; Ryuji Furihata; Toshiaki Onitsuka; Manabu Makinodan; Hiroshi Komatsu; Masahiro Takeshima; Chika Kubota; Akitoyo Hishimoto; Kiyokazu Atake; Hirotaka Yamagata; Mikio Kido; Tatsuya Nagasawa; Masahide Usami; Taishiro Kishimoto; Saya Kikuchi; Junya Matsumoto; Kenichiro Miura; Hisashi Yamada; Koichiro Watanabe; Ken Inada; Ryota Hahimoto
Annals of general psychiatry, Dec. 2022 - Antidepressants for social anxiety disorder: A systematic review and meta-analysis.
Nobuyuki Mitsui; Yutaka Fujii; Satoshi Asakura; Hissei Imai; Hisashi Yamada; Naoki Yoshinaga; Yoshihiro Kanai; Takeshi Inoue; Eiji Shimizu
Neuropsychopharmacology reports, Dec. 2022 - Development of individual fitness score for conformity of prescriptions to the "Guidelines For Pharmacological Therapy of Schizophrenia".
Ken Inada; Kentaro Fukumoto; Naomi Hasegawa; Yuka Yasuda; Hisashi Yamada; Hikaru Hori; Kayo Ichihashi; Hitoshi Iida; Kazutaka Ohi; Hiroyuki Muraoka; Fumitoshi Kodaka; Kenta Ide; Naoki Hashimoto; Jun-Ichi Iga; Kazuyoshi Ogasawara; Kiyokazu Atake; Yoshikazu Takaesu; Tatsuya Nagasawa; Hiroshi Komatsu; Tsuyoshi Okada; Ryuji Furihata; Mikio Kido; Saya Kikuchi; Chika Kubota; Manabu Makinodan; Shinichiro Ochi; Masahiro Takeshima; Hirotaka Yamagata; Junya Matsumoto; Kenichiro Miura; Masahide Usami; Taishiro Kishimoto; Toshiaki Onitsuka; Eiichi Katsumoto; Akitoyo Hishimoto; Shusuke Numata; Norio Yasui-Furukori; Koichiro Watanabe; Ryota Hashimoto
Neuropsychopharmacology reports, Dec. 2022 - Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study.
Shinichiro Ochi; Hiromi Tagata; Naomi Hasegawa; Norio Yasui-Furukori; Jun-Ichi Iga; Hiroko Kashiwagi; Fumitoshi Kodaka; Hiroshi Komatsu; Takashi Tsuboi; Akira Tokutani; Shusuke Numata; Kayo Ichihashi; Toshiaki Onitsuka; Hiroyuki Muraoka; Hitoshi Iida; Kazutaka Ohi; Kiyokazu Atake; Taishiro Kishimoto; Hikaru Hori; Yoshikazu Takaesu; Masahiro Takeshima; Masahide Usami; Manabu Makinodan; Naoki Hashimoto; Michiko Fujimoto; Ryuji Furihata; Tatsuya Nagasawa; Hisashi Yamada; Junya Matsumoto; Kenichiro Miura; Mikio Kido; Akitoyo Hishimoto; Shu-Ichi Ueno; Koichiro Watanabe; Ken Inada; Ryota Hashimoto
The international journal of neuropsychopharmacology, Oct. 2022 - Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site study.
Hiroyuki Muraoka; Fumitoshi Kodaka; Naomi Hasegawa; Norio Yasui-Furukori; Kentaro Fukumoto; Hiroko Kashiwagi; Hiromi Tagata; Hikaru Hori; Kiyokazu Atake; Hitoshi Iida; Kayo Ichihashi; Ryuji Furihata; Takashi Tsuboi; Masahiro Takeshima; Hiroshi Komatsu; Chika Kubota; Shinichiro Ochi; Yoshikazu Takaesu; Masahide Usami; Tatsuya Nagasawa; Manabu Makinodan; Toshinori Nakamura; Mikio Kido; Ikki Ueda; Hirotaka Yamagata; Toshiaki Onitsuka; Takeshi Asami; Akitoyo Hishimoto; Kazuyoshi Ogasawara; Eiichi Katsumoto; Kenichiro Miura; Junya Matsumoto; Kazutaka Ohi; Hisashi Yamada; Koichiro Watanabe; Ken Inada; Katsuji Nishimura; Ryota Hashimoto
Asian journal of psychiatry, Aug. 2022 - Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry.
Kazuyoshi Ogasawara; Shusuke Numata; Naomi Hasegawa; Masahito Nakataki; Manabu Makinodan; Kazutaka Ohi; Masahiro Takeshima; Takashi Tsuboi; Naoki Hashimoto; Toshiaki Onitsuka; Hiroyuki Muraoka; Hikaru Hori; Kayo Ichihashi; Takahiko Inagaki; Norio Yasui-Furukori; Akitoyo Hishimoto; Nobuhiro Sugiyama; Kentaro Fukumoto; Tatsuya Nagasawa; Junya Matsumoto; Yoshikazu Takaesu; Ryuji Furihata; Kiyotaka Nemoto; Toshinori Nakamura; Masahide Usami; Kenichiro Miura; Michiko Fujimoto; Hiromi Tagata; Hisashi Yamada; Hiroshi Komatsu; Shinichiro Ochi; Kiyokazu Atake; Eiichi Katsumoto; Mikio Kido; Taishiro Kishimoto; Taro Suwa; Satoshi Yamamura; Jun-Ichi Iga; Hitoshi Iida; Ken Inada; Koichiro Watanabe; Ryota Hashimoto
Neuropsychopharmacology reports, Jun. 2022 - A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project.
Hisashi Yamada; Mikuni Motoyama; Naomi Hasegawa; Kenichiro Miura; Junya Matsumoto; Kazutaka Ohi; Norio Yasui-Furukori; Shusuke Numata; Masahiro Takeshima; Nobuhiro Sugiyama; Tatsuya Nagasawa; Chika Kubota; Kiyokazu Atake; Takashi Tsuboi; Kayo Ichihashi; Naoki Hashimoto; Takahiko Inagaki; Yoshikazu Takaesu; Jun-Ichi Iga; Hikaru Hori; Toshiaki Onitsuka; Hiroshi Komatsu; Akitoyo Hishimoto; Kentaro Fukumoto; Michiko Fujimoto; Toshinori Nakamura; Kiyotaka Nemoto; Ryuji Furihata; Satoshi Yamamura; Hirotaka Yamagata; Kazuyoshi Ogasawara; Eiichi Katsumoto; Atsunobu Murata; Hitoshi Iida; Shinichiro Ochi; Manabu Makinodan; Mikio Kido; Taishiro Kishimoto; Yuka Yasuda; Masahide Usami; Taro Suwa; Ken Inada; Koichiro Watanabe; Ryota Hashimoto
BJPsych open, Apr. 2022 - Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study.
Norio Yasui-Furukori; Hiroyuki Muraoka; Naomi Hasegawa; Shinichiro Ochi; Shusuke Numata; Hikaru Hori; Akitoyo Hishimoto; Toshiaki Onitsuka; Kazutaka Ohi; Naoki Hashimoto; Tatsuya Nagasawa; Yoshikazu Takaesu; Takahiko Inagaki; Hiromi Tagata; Takashi Tsuboi; Chika Kubota; Ryuji Furihata; Jun-Ichi Iga; Hitoshi Iida; Kenichiro Miura; Junya Matsumoto; Hisashi Yamada; Koichiro Watanabe; Ken Inada; Kazutaka Shimoda; Ryota Hashimoto
Neuropsychopharmacology reports, Mar. 2022 - The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project.
Kayo Ichihashi; Yoshitaka Kyou; Naomi Hasegawa; Norio Yasui-Furukori; Yoshihito Shimizu; Hikaru Hori; Naoki Hashimoto; Kenta Ide; Yayoi Imamura; Hisashi Yamada; Shinichiro Ochi; Jun-Ichi Iga; Yoshikazu Takaesu; Kazutaka Ohi; Takashi Tsuboi; Hitoshi Iida; Hirotaka Yamagata; Akitoyo Hishimoto; Tadasu Horai; Masahide Usami; Manabu Makinodan; Tatsuya Nagasawa; Hiroshi Komatsu; Mikio Kido; Hiroyuki Muraoka; Kiyokazu Atake; Masahiro Takeshima; Chika Kubota; Takahiko Inagaki; Shinichiro Tamai; Taishiro Kishimoto; Ryuji Furihata; Junya Matsumoto; Kenichiro Miura; Ken Inada; Koichiro Watanabe; Kiyoto Kasai; Ryota Hashimoto
Asian journal of psychiatry, Mar. 2022 - Efficacy of a gluten-restricted diet in treatment-resistant schizophrenia patients with immunological gluten sensitivity: A case report.
Mikuni Motoyama; Hisashi Yamada; Kensei Maebayashi; Chiho Yoshimura; Hisato Matsunaga
Schizophrenia research, Mar. 2022 - Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study.
Ryuji Furihata; Rei Otsuki; Naomi Hasegawa; Takashi Tsuboi; Shusuke Numata; Norio Yasui-Furukori; Hiroko Kashiwagi; Hikaru Hori; Shinichiro Ochi; Hiroyuki Muraoka; Toshiaki Onitsuka; Hiroshi Komatsu; Masahiro Takeshima; Akitoyo Hishimoto; Tatsuya Nagasawa; Yoshikazu Takaesu; Toshinori Nakamura; Takeshi Asami; Kenichiro Miura; Junya Matsumoto; Kazutaka Ohi; Yuka Yasuda; Hitoshi Iida; Kazuyoshi Ogasawara; Naoki Hashimoto; Kayo Ichihashi; Hisashi Yamada; Koichiro Watanabe; Ken Inada; Ryota Hashimoto
Sleep medicine, Jan. 2022 - Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics.
Hikaru Hori; Norio Yasui-Furukori; Naomi Hasegawa; Jun-Ichi Iga; Shinichiro Ochi; Kayo Ichihashi; Ryuji Furihata; Yoshitaka Kyo; Yoshikazu Takaesu; Takashi Tsuboi; Fumitoshi Kodaka; Toshiaki Onitsuka; Tsuyoshi Okada; Atsunobu Murata; Hiroko Kashiwagi; Hitoshi Iida; Naoki Hashimoto; Kazutaka Ohi; Hisashi Yamada; Kazuyoshi Ogasawara; Yuka Yasuda; Hiroyuki Muraoka; Masahide Usami; Shusuke Numata; Masahiro Takeshima; Hirotaka Yamagata; Tatsuya Nagasawa; Hiromi Tagata; Manabu Makinodan; Mikio Kido; Eiichi Katsumoto; Hiroshi Komatsu; Junya Matsumoto; Chika Kubota; Kenichiro Miura; Akitoyo Hishimoto; Koichiro Watanabe; Ken Inada; Hiroaki Kawasaki; Ryota Hashimoto
Frontiers in psychiatry, 2022 - Assessment and Treatment of Eating Disorders.
Kazuhiro Yoshiuchi; Hisashi Yamada; Shu Takakura; Masanori Isobe; Koutatsu Maruyama; Toshihiko Nagata
Journal of nutritional science and vitaminology, 2022 - Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project.
Naoki Hashimoto; Norio Yasui-Furukori; Naomi Hasegawa; Shuhei Ishikawa; Shusuke Numata; Hikaru Hori; Hitoshi Iida; Kayo Ichihashi; Ryuji Furihata; Atsunobu Murata; Takashi Tsuboi; Masahiro Takeshima; Yoshitaka Kyou; Hiroshi Komatsu; Chika Kubota; Shinichiro Ochi; Yoshikazu Takaesu; Masahide Usami; Tatsuya Nagasawa; Akitoyo Hishimoto; Kenichiro Miura; Junya Matsumoto; Kazutaka Ohi; Hisashi Yamada; Ken Inada; Koichiro Watanabe; Kazutaka Shimoda; Ryota Hashimoto
Asian journal of psychiatry, Sep. 2021 - Unmet needs of patients with major depressive disorder - Findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.
Hitoshi Iida; Junichi Iga; Naomi Hasegawa; Yuka Yasuda; Tomoya Yamamoto; Kenichiro Miura; Junya Matsumoto; Atsunobu Murata; Kazuyoshi Ogasawara; Hisashi Yamada; Hikaru Hori; Kayo Ichihashi; Naoki Hashimoto; Kazutaka Ohi; Norio Yasui-Furukori; Takashi Tsuboi; Toshinori Nakamura; Masahide Usami; Ryuji Furihata; Yoshikazu Takaesu; Kunihiro Iwamoto; Nobuhiro Sugiyama; Taishiro Kishimoto; Naohisa Tsujino; Hiroki Yamada; Akitoyo Hishimoto; Kiyotaka Nemoto; Kiyokazu Atake; Hiroyuki Muraoka; Eiichi Katsumoto; Satoru Oishi; Takahiko Inagaki; Fumiaki Ito; Yayoi Imamura; Mikio Kido; Tatsuya Nagasawa; Shusuke Numata; Shinichiro Ochi; Masaaki Iwata; Hidenaga Yamamori; Junichi Fujita; Toshiaki Onitsuka; Satoshi Yamamura; Manabu Makinodan; Michiko Fujimoto; Yoichiro Takayanagi; Kenji Takezawa; Hiroshi Komatsu; Kentaro Fukumoto; Shinichiro Tamai; Hirotaka Yamagata; Chika Kubota; Tadasu Horai; Ken Inada; Koichiro Watanabe; Hiroaki Kawasaki; Ryota Hashimoto
Psychiatry and clinical neurosciences, Dec. 2020 - Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project.
Kayo Ichihashi; Hikaru Hori; Naomi Hasegawa; Yuka Yasuda; Tomoya Yamamoto; Takashi Tsuboi; Kunihiro Iwamoto; Taishiro Kishimoto; Tadasu Horai; Hiroki Yamada; Nobuhiro Sugiyama; Toshinori Nakamura; Naohisa Tsujino; Kiyotaka Nemoto; Satoru Oishi; Masahide Usami; Eiichi Katsumoto; Hidenaga Yamamori; Hiroaki Tomita; Taro Suwa; Ryuji Furihata; Takahiko Inagaki; Junichi Fujita; Toshiaki Onitsuka; Kenichiro Miura; Junya Matsumoto; Kazutaka Ohi; Yuki Matsui; Yoshikazu Takaesu; Naoki Hashimoto; Junichi Iga; Kazuyoshi Ogasawara; Hisashi Yamada; Koichiro Watanabe; Ken Inada; Ryota Hashimoto
Neuropsychopharmacology reports, Sep. 2020 - Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.
Yoshikazu Takaesu; Koichiro Watanabe; Shusuke Numata; Masaaki Iwata; Noriko Kudo; Satoru Oishi; Takeya Takizawa; Kiyotaka Nemoto; Yuka Yasuda; Hiromi Tagata; Takashi Tsuboi; Naohisa Tsujino; Naoki Hashimoto; Yuki Matsui; Hikaru Hori; Hidenaga Yamamori; Nobuhiro Sugiyama; Taro Suwa; Taishiro Kishimoto; Akitoyo Hishimoto; Masahide Usami; Ryuji Furihata; Kunihiro Iwamoto; Hiroshige Fujishiro; Toshinori Nakamura; Kentaro Mizuno; Takahiko Inagaki; Eiichi Katsumoto; Hiroaki Tomita; Kazutaka Ohi; Hiroyuki Muraoka; Kiyokazu Atake; Hitoshi Iida; Tatsuya Nagasawa; Junichi Fujita; Satoshi Yamamura; Toshiaki Onitsuka; Atsunobu Murata; Yoichiro Takayanagi; Hokuto Noda; Yukiko Matsumura; Kenji Takezawa; Jun-Ichi Iga; Kayo Ichihashi; Kazuyoshi Ogasawara; Hisashi Yamada; Ken Inada; Ryota Hashimoto
Psychiatry and clinical neurosciences, Oct. 2019 - Elevated anti-gliadin IgG antibodies are related to treatment resistance in schizophrenia.
Mikuni Motoyama; Hisashi Yamada; Masamichi Motonishi; Hisato Matsunaga
Comprehensive psychiatry, Aug. 2019 - Ten-year follow-up study of Japanese patients with obsessive-compulsive disorder.
Akihiro Nakajima; Naomi Matsuura; Keiichiro Mukai; Kyosuke Yamanishi; Hisashi Yamada; Kensei Maebayashi; Kazuhisa Hayashida; Hisato Matsunaga
Psychiatry and clinical neurosciences, Jul. 2018 - Psychometric properties of the Japanese version of the Social Phobia Inventory.
Toshihiko Nagata; Takenori Nakajima; Alan R Teo; Hisashi Yamada; Chiho Yoshimura
Psychiatry and clinical neurosciences, Apr. 2013 - Using the mood disorder questionnaire and bipolar spectrum diagnostic scale to detect bipolar disorder and borderline personality disorder among eating disorder patients.
Toshihiko Nagata; Hisashi Yamada; Alan R Teo; Chiho Yoshimura; Yuya Kodama; Irene van Vliet
BMC psychiatry, Feb. 2013 - Comorbid social withdrawal (hikikomori) in outpatients with social anxiety disorder: clinical characteristics and treatment response in a case series.
Toshihiko Nagata; Hisashi Yamada; Alan R Teo; Chiho Yoshimura; Takenori Nakajima; Irene van Vliet
The International journal of social psychiatry, Feb. 2013 - Recovery of low plasma BDNF over the course of treatment among patients with bulimia nervosa.
Hisashi Yamada; Chiho Yoshimura; Takenori Nakajima; Toshihiko Nagata
Psychiatry research, Aug. 2012 - Correlations between the offensive subtype of social anxiety disorder and personality disorders.
Toshihiko Nagata; Hisato Matsunaga; Irene van Vliet; Hisashi Yamada; Hidehiro Fukuhara; Chiho Yoshimura; Nobuo Kiriike
Psychiatry and clinical neurosciences, Jun. 2011
